A distinct epigenetic signature at targets of a leukemia protein

BMC Genomics

Volumn 8, Issue , 2007, Pages

  Rossetti, Stefano ^a   Hoogeveen, André T ^b   Liang, Ping ^a   Stanciu, Cornel ^a   van der Spek, Peter ^b   Sacchi, Nicoletta ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; HISTONE; HYBRID PROTEIN; ONCOPROTEIN; PROTEIN MTG16; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR RUNX; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOINFORMATICS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN; CHROMOSOME 16Q; CHROMOSOME 8Q; CHROMOSOME TRANSLOCATION 16; CHROMOSOME TRANSLOCATION 8; CONSENSUS SEQUENCE; CONTROLLED STUDY; CPG ISLAND; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION PROFILING; GENE TARGETING; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GRANULOCYTE; LEUKEMOGENESIS; METHYLATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; UNINDEXED SEQUENCE;

ANIMALS; CELLS, CULTURED; CHROMATIN; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 21; CONSENSUS SEQUENCE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CPG ISLANDS; DOWN-REGULATION; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GENE SILENCING; GRANULOCYTE COLONY-STIMULATING FACTOR; HISTONES; HUMANS; INTERLEUKIN-3; LEUKEMIA, MYELOID; MICE; MYELOID CELLS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS, FUSION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; TRANSCRIPTION INITIATION SITE; TRANSFECTION; TRANSLOCATION, GENETIC;

EID: 33846960733     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-8-38     Document Type: Article

References (47)

1. Rosmarin AG Yang Z Resendes KK Transcriptional regulation in myelopoiesis: Hematopoietic fate choice, myeloid differentiation, and leukemogenesis Exp Hematol 2005 33 131-143 10.1016/j.exphem.2004.08.015 15676205
2. Evans T Regulation of hematopoiesis by retinoid signaling Exp Hematol 2005 33 1055-1061 10.1016/j.exphem.2005.06.007 16140154
3. Kitabayashi I Yokoyama A Shimizu K Ohki M Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation Embo J 1998 17 2994-3004 1170639 9606182 10.1093/ emboj/17.11.2994
4. Michaud J Scott HS Escher R AML1 interconnected pathways of leukemogenesis Cancer Invest 2003 21 105-136 10.1081/CNV-120018821 12643014
5. Otto F Lubbert M Stock M Upstream and downstream targets of RUNX proteins J Cell Biochem 2003 89 9-18 10.1002/jcb.10491 12682904
6. Yamagata T Maki K Mitani K Runx1/AML1 in normal and abnormal hematopoiesis Int J Hematol 2005 82 1-8 10.1532/IJH97.05075 16105753
7. Meyers S Downing JR Hiebert SW Identification of AML-1 and the (8;21) translocation protein (AML- 1/ETO) as sequence-specific DNA-binding proteins: The runt homology domain is required for DNA binding and protein-protein interactions Mol Cell Biol 1993 13 6336-6345 364692 8413232
8. Scandura JM Boccuni P Cammenga J Nimer SD Transcription factor fusions in acute leukemia: Variations on a theme Oncogene 2002 21 3422-3444 10.1038/sj.onc.1205315 12032780
9. Song WJ Sullivan MG Legare RD Hutchings S Tan X Kufrin D Ratajczak J Resende IC Haworth C Hock R Loh M Felix C Roy DC Busque L Kurnit D Willman C Gewirtz AM Speck NA Bushweller JH Li FP Gardiner K Poncz M Maris JM Gilliland DG Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia Nat Genet 1999 23 166-175 10.1038/13793 10508512
10. Miyoshi H Shimizu K Kozu T Maseki N Kaneko Y Ohki M t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1 Proc Natl Acad Sci U S A 1991 88 10431-10434 52942 1720541 10.1073/pnas.88.23.10431
11. Erickson P Gao J Chang KS Look T Whisenant E Raimondi S Lasher R Trujillo J Rowley J Drabkin H Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ ETO, with similarity to Drosophila segmentation gene, runt Blood 1992 80 1825-1831 1391946
12. Nisson PE Watkins PC Sacchi N Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8;21) leukemic cells [published erratum appears in Cancer Genet Cytogenet 1993 Mar;66(1):81] Cancer Genet Cytogenet 1992 63 81-88 10.1016/0165-4608(92)90384-K 1423235
13. Gamou T Kitamura E Hosoda F Shimizu K Shinohara K Hayashi Y Nagase T Yokoyama Y Ohki M The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family Blood 1998 91 4028-4037 9596646
14. Hiebert SW Lutterbach B Amann J Role of co-repressors in transcriptional repression mediated by the t(8;21), t(16;21), t(12;21), and inv(16) fusion proteins Curr Opin Hematol 2001 8 197-200 10.1097/ 00062752-200107000-00003 11561155
15. Rossetti S Hoogeveen AT Sacchi N The MTG proteins: Chromatin repression players with a passion for networking Genomics 2004 84 1-9 10.1016/ j.ygeno.2004.02.011 15203199
16. Minucci S Maccarana M Cioce M De Luca P Gelmetti V Segalla S Di Croce L Giavara S Matteucci C Gobbi A Bianchini A Colombo E Schiavoni I Badaracco G Hu X Lazar MA Landsberger N Nervi C Pelicci PG Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation Mol Cell 2000 5 811-820 10.1016/ S1097-2765(00)80321-4 10882117
17. Zhang J Hug BA Huang EY Chen CW Gelmetti V Maccarana M Minucci S Pelicci PG Lazar MA Oligomerization of ETO is obligatory for corepressor interaction Mol Cell Biol 2001 21 156-163 88789 11113190 10.1128/ MCB.21.1.156-163.2001
18. Liu Y Cheney MD Gaudet JJ Chruszcz M Lukasik SM Sugiyama D Lary J Cole J Dauter Z Minor W Speck NA Bushweller JH The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity Cancer Cell 2006 9 249-260 10.1016/j.ccr.2006.03.012 16616331
19. Rossetti S Van Unen L Touw IP Hoogeveen AT Sacchi N Myeloid maturation block by AML1-MTG16 is associated with Csf1r epigenetic downregulation Oncogene 2005 24 5325-5332 10.1038/sj.onc.1208651 16007222
20. Ahn MY Huang G Bae SC Wee HJ Kim WY Ito Y Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dcl3 by ear-2, a mammalian homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1/ETO Proc Natl Acad Sci U S A 1998 95 1812-1817 19195 9465099 10.1073/pnas.95.4.1812
21. Kohzaki H Ito K Huang G Wee HJ Murakami Y Ito Y Block of granulocytic differentiation of 32Dcl3 cells by AML1/ETO(MTG8) but not by highly expressed Bcl-2 Oncogene 1999 18 4055-4062 10.1038/sj.onc.1202735 10435586
22. Kinet JP The high-affinity IgE receptor (Fc epsilon RI): From physiology to pathology Annu Rev Immunol 1999 17 931-972 10.1146/ annurev.immunol.17.1.931 10358778
23. Rehli M Sulzbacher S Pape S Ravasi T Wells CA Heinz S Sollner L El Chartouni C Krause SW Steingrimsson E Hume DA Andreesen R Transcription factor Tfec contributes to the IL-4-inducible expression of a small group of genes in mouse macrophages including the granulocyte colony-stimulating factor receptor J Immunol 2005 174 7111-7122 15908341
24. Rehli M Lichanska A Cassady AI Ostrowski MC Hume DA TFEC is a macrophage-restricted member of the microphthalmia-TFE subfamily of basic helix-loop-helix leucine zipper transcription factors J Immunol 1999 162 1559-1565 9973413
25. Altin JG Sloan EK The role of CD45 and CD45-associated molecules in T cell activation Immunol Cell Biol 1997 75 430-445 9429890
26. Coughlin SR Thrombin signalling and protease-activated receptors Nature 2000 407 258-264 10.1038/35025229 11001069
27. Gerson SL MGMT: Its role in cancer aetiology and cancer therapeutics Nat Rev Cancer 2004 4 296-307 10.1038/nrc1319 15057289
28. Hoogeveen AT Rossetti S Stoyanova V Schonkeren J Fenaroli A Schiaffonati L Van Unen L Sacchi N The transcriptional corepressor MTG16a contains a novel nucleolar targeting sequence deranged in t (16; 21)-positive myeloid malignancies Oncogene 2002 21 6703-6712 10.1038/sj.onc.1205882 12242670
29. Jenuwein T Allis CD Translating the histone code Science 2001 293 1074-1080 10.1126/science.1063127 11498575
30. Berger SL Histone modifications in transcriptional regulation Curr Opin Genet Dev 2002 12 142-148 10.1016/S0959-437X(02)00279-4 11893486
31. Peterson CL Laniel MA Histones and histone modifications Curr Biol 2004 14 R546-51 10.1016/j.cub.2004.07.007 15268870
32. Fuks F DNA methylation and histone modifications: Teaming up to silence genes Curr Opin Genet Dev 2005 15 490-495 10.1016/j.gde.2005.08.002 16098738
33. Burgers WA Fuks F Kouzarides T DNA methyltransferases get connected to chromatin Trends Genet 2002 18 275-277 10.1016/S0168-9525(02)02667-7 12044346
34. Takai D Jones PA The CpG island searcher: A new WWW resource In Silico Biol 2003 3 235-240 12954087
35. Iwakuma T Shiraishi A Fukuhara M Kawate H Sekiguchi M Organization and expression of the mouse gene for DNA repair methyltransferase DNA Cell Biol 1996 15 863-872 8892758
36. Kouzarides T Histone methylation in transcriptional control Curr Opin Genet Dev 2002 12 198-209 10.1016/S0959-437X(02)00287-3 11893494
37. Bistulfi G Pozzi S Ren M Rossetti S Sacchi N A repressive epigenetic domino effect confers susceptibility to breast epithelial cell transformation: Implications for predicting breast cancer risk Cancer Res 2006 66 10308-10314 10.1158/0008-5472.CAN-06-1052 17079450
38. Pozzi S Rossetti S Bistulfi G Sacchi N RAR-mediated epigenetic control of the cytochrome P450 Cyp26a1 in embryocarcinoma cells Oncogene 2006 25 1400-1407 10.1038/sj.onc.1209173 16261163
39. Galm O Wilop S Luders C Jost E Gehbauer G Herman JG Osieka R Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia Ann Hematol 2005 84 Suppl 13 39-46 10.1007/s00277-005-0005-0 16231140
40. Esteller M Herman JG Generating mutations but providing chemosensitivity: The role of O6-methylguanine DNA methyltransferase in human cancer Oncogene 2004 23 1-8 10.1038/sj.onc.1207316 14712205
41. Alcalay M Meani N Gelmetti V Fantozzi A Fagioli M Orleth A Riganelli D Sebastiani C Cappelli E Casciari C Sciurpi MT Mariano AR Minardi SP Luzi L Muller H Di Fiore PP Frosina G Pelicci PG Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair J Clin Invest 2003 112 1751-1761 281638 14660751 10.1172/ JCI200317595
42. Dunne J Cullmann C Ritter M Soria NM Drescher B Debernardi S Skoulakis S Hartmann O Krause M Krauter J Neubauer A Young BD Heidenreich O siRNA-mediated AML1/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8;21)-positive cell lines and primary AML blasts Oncogene 2006 25 6067-6078 10.1038/sj.onc.1209638 16652140
43. Shimada H Ichikawa H Nakamura S Katsu R Iwasa M Kitabayashi I Ohki M Analysis of genes under the downstream control of the t(8;21) fusion protein AML1-MTG8: Overexpression of the TIS11b (ERF-1, cMG1) gene induces myeloid cell proliferation in response to G-CSF Blood 2000 96 655-663 10887131
44. Shimada H Ichikawa H Ohki M Potential involvement of the AML1-MTG8 fusion protein in the granulocytic maturation characteristic of the t(8;21) acute myelogenous leukemia revealed by microarray analysis Leukemia 2002 16 874-885 10.1038/sj.leu.2402465 11986950
45. Di Croce L Raker VA Corsaro M Fazi F Fanelli M Faretta M Fuks F Lo Coco F Kouzarides T Nervi C Minucci S Pelicci PG Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor Science 2002 295 1079-1082 10.1126/science.1065173 11834837
46. Bailey TL Elkan C Fitting a mixture model by expectation maximization to discover motifs in biopolymers Proc Int Conf Intell Syst Mol Biol 1994 2 28-36 7584402
47. Herman JG Graff JR Myohanen S Nelkin BD Baylin SB Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci U S A 1996 93 9821-9826 38513 8790415 10.1073/pnas.93.18.9821